New Data at ACC.26 Demonstrating UltraSight™ AI Enables Non-Experts to Perform Diagnostic Cardiac Ultrasound

UltraSight™, a leader in AI-guided cardiac imaging, today announced that six clinical studies validating the performance of its UltraSight™ Echosystem will be presented at the 2026 American College of Cardiology’s Annual Scientific Session & Expo (ACC.26). The studies, conducted in collaboration with Mayo Clinic, confirm that the UltraSight™ Echosystem enables healthcare professionals without prior sonography training to acquire diagnostic-quality cardiac ultrasound images with greater than 95% accuracy across multiple patient populations and care settings.

Publish date

March 18, 2026